Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunle Odunsi

Showing results (1-10 of 339) with videos related to

Pageof 34
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|February 22, 2023
Perspectives on Disparities and Equity in Cancer Outcomes: A Call to ActionKunle Odunsi
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Adoptive cell therapy for ovarian cancerKunle Odunsi
JAMA Oncology|June 14, 2019
Immune Checkpoint and Poly(ADP-Ribose) Polymerase Inhibition for Recurrent Platinum-Resistant Ovarian and Metastatic Triple-Negative Breast CancersKunle Odunsi, Tanja Pejovic
The New England Journal of Medicine|November 3, 2021
RNA Splicing and Immune-Checkpoint InhibitionLi Ding, Kunle Odunsi
Expert Opinion on Therapeutic Targets|June 14, 2005
Targeted therapy for epithelial ovarian cancerSameer Sharma, Kunle Odunsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Immunologic approaches to ovarian cancer treatmentPaul Sabbatini, Kunle Odunsi
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 25, 2007
Harnessing the immune system for ovarian cancer therapyKunle Odunsi, Paul Sabbatini
Gynecologic Oncology|December 3, 2014
Tumor-associated macrophages: co-conspirators and orchestrators of immune suppression in endometrial adenocarcinomaEmese Zsiros, Kunle Odunsi
Cold Spring Harbor Perspectives in Medicine|April 15, 2024
Harnessing Antitumor Immunity in Ovarian CancerKatherine C Kurnit, Kunle Odunsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Adoptive Cell Therapy for Nonhematologic Solid TumorsDaniel J Olson, Kunle Odunsi
Pageof 34

Showing results (1-10 of 339) with videos related to

Sort By:
Pageof 34
Academic Medicine : Journal of the Association of American Medical Colleges|February 22, 2023
Perspectives on Disparities and Equity in Cancer Outcomes: A Call to ActionKunle Odunsi
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Adoptive cell therapy for ovarian cancerKunle Odunsi
JAMA Oncology|June 14, 2019
Immune Checkpoint and Poly(ADP-Ribose) Polymerase Inhibition for Recurrent Platinum-Resistant Ovarian and Metastatic Triple-Negative Breast CancersKunle Odunsi, Tanja Pejovic
The New England Journal of Medicine|November 3, 2021
RNA Splicing and Immune-Checkpoint InhibitionLi Ding, Kunle Odunsi
Expert Opinion on Therapeutic Targets|June 14, 2005
Targeted therapy for epithelial ovarian cancerSameer Sharma, Kunle Odunsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Immunologic approaches to ovarian cancer treatmentPaul Sabbatini, Kunle Odunsi
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 25, 2007
Harnessing the immune system for ovarian cancer therapyKunle Odunsi, Paul Sabbatini
Gynecologic Oncology|December 3, 2014
Tumor-associated macrophages: co-conspirators and orchestrators of immune suppression in endometrial adenocarcinomaEmese Zsiros, Kunle Odunsi
Cold Spring Harbor Perspectives in Medicine|April 15, 2024
Harnessing Antitumor Immunity in Ovarian CancerKatherine C Kurnit, Kunle Odunsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Adoptive Cell Therapy for Nonhematologic Solid TumorsDaniel J Olson, Kunle Odunsi
Pageof 34